Literature DB >> 15199150

p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Zaineb R Abdul Razak1, Robert J Varkonyi, Michelle Kulp-McEliece, Corrado Caslini, Joseph R Testa, Maureen E Murphy, Dominique Broccoli.   

Abstract

Telomere stabilization is critical for tumorigenesis. A number of tumors and cell lines use a recombination-based mechanism, alternative lengthening of telomeres (ALT), to maintain telomere repeat arrays. Current data suggest that the mutation of p53 facilitates the activation of this pathway. In addition to its functions in response to DNA damage, p53 also acts to suppress recombination, independent of transactivation activity, raising the possibility that p53 might regulate the ALT mechanism via its role as a regulator of recombination. To test the role of p53 in ALT we utilized inducible alleles of human p53. We show that expression of transactivation-incompetent p53 inhibits DNA synthesis in ALT cell lines but does not affect telomerase-positive cell lines. The expression of temperature-sensitive p53 in clonal cell lines results in ALT-specific, transactivation-independent growth inhibition, due in part to the perturbation of S phase. Utilizing chromatin immunoprecipitation assays, we demonstrate that p53 is associated with the telomeric complex in ALT cells. Furthermore, the inhibition of DNA synthesis in ALT cells by p53 requires intact specific DNA binding and suppression of recombination functions. We propose that p53 causes transactivation-independent growth inhibition of ALT cells by perturbing telomeric recombination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199150      PMCID: PMC480899          DOI: 10.1128/MCB.24.13.5967-5977.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint.

Authors:  Y Saintigny; D Rouillard; B Chaput; T Soussi; B S Lopez
Journal:  Oncogene       Date:  1999-06-17       Impact factor: 9.867

2.  Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.

Authors:  H Willers; E E McCarthy; B Wu; H Wunsch; W Tang; D G Taghian; F Xia; S N Powell
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

3.  Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA.

Authors:  H Niida; Y Shinkai; M P Hande; T Matsumoto; S Takehara; M Tachibana; M Oshimura; P M Lansdorp; Y Furuichi
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Telomere maintenance by recombination in human cells.

Authors:  M A Dunham; A A Neumann; C L Fasching; R R Reddel
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

5.  A transactivation-deficient mouse model provides insights into Trp53 regulation and function.

Authors:  G S Jimenez; M Nister; J M Stommel; M Beeche; E A Barcarse; X Q Zhang; S O'Gorman; G M Wahl
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae.

Authors:  S C Teng; V A Zakian
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres.

Authors:  G Wu; W H Lee; P L Chen
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Hot-spot mutants of p53 core domain evince characteristic local structural changes.

Authors:  K B Wong; B S DeDecker; S M Freund; M R Proctor; M Bycroft; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

9.  Loss of wild-type p53 function is responsible for upregulated homologous recombination in immortal rodent fibroblasts.

Authors:  H Willers; E E McCarthy; W Alberti; J Dahm-Daphi; S N Powell
Journal:  Int J Radiat Biol       Date:  2000-08       Impact factor: 2.694

10.  ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.

Authors:  J V Grobelny; A K Godwin; D Broccoli
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  11 in total

1.  Short Telomeres Induce p53 and Autophagy and Modulate Age-Associated Changes in Cardiac Progenitor Cell Fate.

Authors:  Collin Matsumoto; Yan Jiang; Jacqueline Emathinger; Pearl Quijada; Nathalie Nguyen; Andrea De La Torre; Maryam Moshref; Jonathan Nguyen; Aimee B Levinson; Minyoung Shin; Mark A Sussman; Nirmala Hariharan
Journal:  Stem Cells       Date:  2018-02-25       Impact factor: 6.277

Review 2.  Means to the ends: The role of telomeres and telomere processing machinery in metastasis.

Authors:  Nathaniel J Robinson; William P Schiemann
Journal:  Biochim Biophys Acta       Date:  2016-10-18

3.  Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway.

Authors:  Purnima R Laud; Asha S Multani; Susan M Bailey; Ling Wu; Jin Ma; Charles Kingsley; Michel Lebel; Sen Pathak; Ronald A DePinho; Sandy Chang
Journal:  Genes Dev       Date:  2005-11-01       Impact factor: 11.361

4.  Correlations of telomere length, P53 mutation, and chromosomal translocation in soft tissue sarcomas.

Authors:  Chunxia Liu; Bingcheng Li; Li Li; Haijun Zhang; Yunzhao Chen; Xiaobin Cui; Jianming Hu; Jingfang Jiang; Yan Qi; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.

Authors:  L Weng; D Ziliak; H K Im; E R Gamazon; S Philips; A T Nguyen; Z Desta; T C Skaar; D A Flockhart; R S Huang
Journal:  Ann Oncol       Date:  2013-03-18       Impact factor: 32.976

6.  MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription.

Authors:  Corrado Caslini; James A Connelly; Amparo Serna; Dominique Broccoli; Jay L Hess
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

7.  Neighborhood properties are important determinants of temperature sensitive mutations.

Authors:  Svetlana Lockwood; Bala Krishnamoorthy; Ping Ye
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.

Authors:  Yan Xue; Lei Li; Dong Zhang; Kaijie Wu; Yule Chen; Jin Zeng; Xinyang Wang; Dalin He
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

9.  Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins.

Authors:  Wei-Qin Jiang; Ze-Huai Zhong; Akira Nguyen; Jeremy D Henson; Christian D Toouli; Antony W Braithwaite; Roger R Reddel
Journal:  J Cell Biol       Date:  2009-05-25       Impact factor: 10.539

Review 10.  PML body meets telomere: the beginning of an ALTernate ending?

Authors:  Inn Chung; Sarah Osterwald; Katharina I Deeg; Karsten Rippe
Journal:  Nucleus       Date:  2012-05-01       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.